Table 1 Sequences of oligonucleotide primers used in this study
From: Properties of resistant cells generated from lung cancer cell lines treated with EGFR inhibitors
Gene | Forward | Reverse |
|---|---|---|
E-cadherin | 5'-AGGAATTCTTGCTTTGCTAATTCTG | 5'-CGAAGAAACAGCAAGAGCAGC |
Vimentin | 5'-GAGAACTTTGCCGTTGAAGC | 5'-CTAACGGTGGATGTCCTTCG |
Fibronectin | 5'-GTT GTT ACC GTG GGC AAC TC | 5'-CTG ACG GTC CCA CTT CTC TC |
Occludin | 5'-TTGGGACAGAGGCTATGG | 5'-ACCCACTCTTCAACATTGGG |
Snail | 5'-TTCCAGCAGCCCAACGACCAG | 5'-CGGACTCTTGGTGCTTGTGGA |
Twist | 5'-GGAGTCCGCAGTCTTACGAG | 5'-TCTGGAGGACCTGGTAGAGG |
Oct3/4 | 5'-CAGTGCCCGAAACCCACAC | 5'-GGAGACCCAGCAGCCTCAAA |
SOX2 | 5'-CAAGATGCACAACTCGGAGA | 5'-GTTCATGTGCGCGTAACTGT |
NANOG | 5'-CAGAAGGCCTCAGCACCTAC | 5'-ATTGTTCCAGGTCTGGTTGC |
ID2 | 5'-GACCCGATGAGCCTGCTATAC | 5'-AATAGTGGGATGCGAGTCCAG |
BMI-1 | 5'-GATGCCACAACCATAATAGAA | 5'-TCATTCACCTCCTCCTTAGAT |
STAT3 | 5'-GGGTGGAGAAGGACATCAGCGGTAA | 5'-GCCGACAATACTTTCCGAATGC |